In an effort to increase patient accrual, broaden patients’ access to cancer clinical trials, and lead to trial results that better represent treatment effects in the real world, the FDA published 4 ...
Please provide your email address to receive an email when new articles are posted on . Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology ...
“A Tool, Not a Crutch”: Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering The National Minority Quality Forum and Sustainable Healthy Communities Diverse Cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results